REG-Millennium Partners, L.P. Form 8.3 - Horizon Therapeutics plc

Horizon TherapeuticsAnnouncement

06/10/2023 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231006:nBw8dvW9wa&default-theme=true


Form 8.3 - Horizon Therapeutics plc

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE

1. KEY INFORMATION
 Name of person dealing (Note 1)                                                Millennium International Management LP  
 Company dealt in                                                               Horizon Therapeutics plc                
 Class of relevant security to which the dealings being disclosed relate (Note  IE00BQPVQZ61                            
 2)                                                                                                                     
 Date of dealing                                                                5(th) October 2023                      


2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
                                              Long                Short               
                                              Number        (%)   Number        (%)   
 (1) Relevant securities                      8,884,725           -                   
                                              
                                       
                                              
(3.881%)                               
 (2) Derivatives (other than options)         2,400,000           -                   
                                              
                                       
                                              
(1.048%)                               
 (3) Options and agreements to purchase/sell  872,900             937,000             
                                              
                   
                   
                                              
(0.381%)           
(0.409%)           
 Total                                        12,157,625          937,000             
                                              
                   
                   
                                              
(5.311%)           
(0.409%)           


(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
 Class of relevant security:                   Long             Short            
                                               Number      (%)  Number      (%)  
 (1) Relevant securities                                                         
                                                                                 
 
                                                                               
 
(2) Derivatives (other than options)                                           
                                                                                 
 
                                                                               
 
(3) Options and agreements to purchase/sell                                    
 Total                                                                           
                                                                
                
                                                                
                


Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales
                                                                                 
 
               
                               
                               
 
Purchase/sale  
Number of relevant securities  
Price per unit (USD) (Note 5)  
 Purchase        67                              116.34                          
 Sale            354                             116.34                          
 Sale            4                               116.35                          
 Sale            11                              116.37                          
 Sale            27                              116.36                          
 Purchase        317                             116.33                          
 Sale            46                              116.33                          
 Purchase        225                             116.32                          
 Sale            513                             116.32                          
 Purchase        3,047,847                       116.30                          
 Purchase        2,662                           116.34                          
 Purchase        3,063                           116.35                          
 Purchase        10                              116.37                          
 Purchase        10                              116.36                          
 Purchase        26,948                          116.33                          
 Purchase        7,496                           116.32                          
 Purchase        432                             116.31                          
 Purchase        1,600,000                       116.30                          
 Purchase        25,553                          116.33                          
 Purchase        500                             116.32                          
 Sale            18,961                          116.34                          
 Sale            1,000                           116.35                          
 Sale            80,077                          116.33                          
 Purchase        2                               116.31                          
 Purchase        30,000                          116.30                          


(b) Derivatives transactions (other than options transactions)
 Product name,  Nature of transaction    Number of relevant securities  Price per unit (USD)  
 
              
                        
                              
                     
 
e.g. CFD      
(Note 6)                
(Note 7)                      
(Note 5)             
 Equity Swap    Opening a long position  2,400,000                      116.30                


(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying
 Product name,      Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc.  Expiry date  Option money paid/received per unit (Note 5)  
 
                                                                                                                         
                                                                                                              
 
e.g. call option                                                                                                         
(USD)                                                                                                         
 Put Option         Selling                                     100,000                                                    115.00          American                            10/20/2023                                                 


(ii) Exercising
 Product name,      Number of securities  Exercise price per unit (Note 5)  
 
                                                                          
 
e.g. call option                                                          
                                                                            
                                                                            
                                                                            


(d) Other dealings (including transactions in respect of new securities) (Note
4)
 Nature of transaction  Details  Price per unit             
 
                               
                          
 
(Note 8)                       
(if applicable) (Note 5)  
                                                            


Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES
 Date of disclosure                                                6(th) October 2023  
 Contact name                                                      Stephen Glasper     
 Telephone number                                                  +44 203 398 2166    
 If a connected EFM, name of offeree/offeror with which connected                      
 If a connected EFM, state nature of connection (Note 10)                              


Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION
 Full name of person making            Millennium International Management LP  
 
disclosure:                                                                  
 Name of offeror/offeree in relation   Horizon Therapeutics plc                
 
to whose relevant securities the                                             
 
disclosure relates:                                                          


2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 Class of      Product        Written or   Number of        Exercise   Type         Expiry      
 
relevant     
description   
purchased   
securities to   
price     
e.g.        
date       
 
security     
e.g. call                  
which option    
per unit  
American,               
               
option                     
or derivative   
          
European                
                                           
relates         
(USD)     
etc.                    
 IE00BQPVQZ61  Put Option     Purchased    300              80.00      American     1/17/2025   
 IE00BQPVQZ61  Put Option     Purchased    100,300          90.00      American     1/19/2024   
 IE00BQPVQZ61  Put Option     Written      284,900          60.00      American     12/15/2023  
 IE00BQPVQZ61  Put Option     Written      100,000          65.00      American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    55,000           70.00      American     1/19/2024   
 IE00BQPVQZ61  Put Option     Written      41,500           45.00      American     1/19/2024   
 IE00BQPVQZ61  Put Option     Purchased    250,000          85.00      American     1/19/2024   
 IE00BQPVQZ61  Call Option    Purchased    152,500          110.00     American     11/17/2023  
 IE00BQPVQZ61  Call Option    Purchased    4,500            110.00     American     10/20/2023  
 IE00BQPVQZ61  Call Option    Purchased    100,000          100.00     American     12/15/2023  
 IE00BQPVQZ61  Call Option    Written      100,000          110.00     American     12/15/2023  
 IE00BQPVQZ61  Call Option    Written      3,400            100.00     American     10/20/2023  
 IE00BQPVQZ61  Call Option    Purchased    2,800            100.00     American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    150,000          85.00      American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    2,600            90.00      American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    41,500           65.00      American     1/19/2024   
 IE00BQPVQZ61  Put Option     Written      600              100.00     American     10/20/2023  
 IE00BQPVQZ61  Put Option     Purchased    100,000          70.00      American     11/17/2023  
 IE00BQPVQZ61  Call Option    Purchased    200              115.00     American     12/15/2023  
 IE00BQPVQZ61  Put Option     Written      100,000          60.00      American     1/19/2024   
 IE00BQPVQZ61  Call Option    Purchased    35,200           110.00     American     1/19/2024   
 IE00BQPVQZ61  Call Option    Written      54,800           115.00     American     1/19/2024   
 IE00BQPVQZ61  Call Option    Written      400              105.00     American     11/17/2023  
 IE00BQPVQZ61  Put Option     Written      400              105.00     American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    27,000           95.00      American     10/20/2023  
 IE00BQPVQZ61  Call Option    Purchased    300              115.00     American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    11,800           115.00     American     11/17/2023  
 IE00BQPVQZ61  Put Option     Purchased    5,300            115.00     American     11/17/2025  
 IE00BQPVQZ61  Put Option     Purchased    5,600            115.00     American     1/19/2024   
 IE00BQPVQZ61  Put Option     Purchased    15,000           115.00     American     10/20/2023  
 IE00BQPVQZ61  Put Option     Purchased    11,400           115.00     American     12/15/2023  
 IE00BQPVQZ61  Put Option     Purchased    600              115.00     American     2/16/2023   
 IE00BQPVQZ61  Put Option     Purchased    600              115.00     American     3/15/2024   
 IE00BQPVQZ61  Put Option     Purchased    400              115.00     American     5/17/2023   
 IE00BQPVQZ61  Put Option     Purchased    1,000            115.00     American     10/27/2023  
 IE00BQPVQZ61  Put Option     Written      50,000           80.00      American     11/17/2023  


3. AGREEMENTS TO PURCHASE OR SELL
 Full details should be given so that the nature of the interest or position  
 can be fully understood:                                                     
                                                                              
 
                                                                            
 
                                                                            
 
                                                                            
 
                                                                            


Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER
EMPLOYEE OPTIONS)
 Class of relevant security in relation to which subscription right exists:       
 Details, including nature of the rights concerned and relevant percentages:      


It is not necessary to provide details on a Supplemental Form with regard to
cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel
Act, 1997, Takeover Rules, 2022.



View source version on businesswire.com:
https://www.businesswire.com/news/home/20231006494608/en/
(https://www.businesswire.com/news/home/20231006494608/en/)

Millennium Partners, L.P.


Copyright Business Wire 2023